内皮生成因子及抗血管内皮生成因子在先兆子痫发病机制中作用的研究进展被引量：7

下载PDF

导出

摘要先兆子痫是妊娠期特有的全身性多系统综合征,其患病率为2%-8%,占孕产妇死亡原因的10%-15%,其临床特点为妊娠20周后出现的蛋白尿和高血压等症状,甚至发生母子死亡。但是由于先兆子痫的发病机制尚未阐明,其早期预测生物指标仍比较匮乏。早期诊断和疾病的防治可减少其潜在的副作用。近年来已有研究表明抗血管生成因子[如可溶性酪氨酸激酶-1（sFlt-1）,

作者郭雪晶古航倪鑫

机构地区第二军医大学附属长海医院妇产科第二军医大学基础部生理教研室

出处《临床和实验医学杂志》 2016年第20期2071-2072,F0003,共3页 Journal of Clinical and Experimental Medicine

关键词先兆子痫血管内皮生成因子抗血管生成因子可溶性络氨酸激酶-1 可溶性内皮糖蛋白生物指标

分类号 R714.244 [医药卫生—妇产科学]

引文网络
相关文献

参考文献2

1陈雪,应豪,杨慧琳.血清PAPP—A、PIGF和sFlt-1在子痫前期患者中的表达及意义[J].医学临床研究,2015,32(7):1277-1279. 被引量：16
2何勤径,曹永利,朱琦,杨丽芳,霍雷.VEGF及其受体sFlt-1在早发型和晚发型重度子痫前期表达的临床研究[J].国际医药卫生导报,2012,18(12):1724-1726. 被引量：4

二级参考文献21

1吕艳关,臧晓娟,范广来,等.胎盘组织缺氧诱导因子-1A的表达和血管内皮生长因子及其受体-1水平在子痫前期的作用研究[J].中华临床医师杂志,2013,11(10):4825-4829.
2Bergmann A,Ahmad S,Cudmore M. Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model[J].Journal of Cellular and Molecular Medicine,2010,(6B):1857-1867.
3Brouillet S,Hoffmann P,Chauvet S. Revisiting the role of hCG:new regulation of the angiogenic factor EG-VEGF and its receptors[J].Cellular and Molecular Life Sciences,2012,(09):1537-1550.doi:10.1007/s00018-011-0889-x.
4Chedraui P, Lockwood CJ, Schatz F, et al . Increased plasma soluble fms-like tyrosine kinas and ennobling levels in preg- nancies complicated with preeclampsia [J]. J Matern Fetal Neonatal Med, 2013, 22(7): 565-570.
5Koenig W. High-sensitivity C-reactive protein and atheroscle- rotie disease: from improved risk prediction to risk-guided therapy [J]. Int J Cardiol, 2013, 168(6):5126-5134.
6Pilalis A, Souka AP, Antsaklis P, et al . Screening for pre-ee- lampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11 14 weeks" gestation[J]. Ultrasound Obstet Gynecol, 2007,29(2) : 135-140.
7Polliotti BM, Fry AG, Sailer DN. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclarapsia [J]. Obstet Gynecol, 2003,101(6) :1266-1274.
8Kim SY,Ryu HM,Yang JH, et al . Increased sFlt-1 to PLGF ratio in women who subsequently develop preeelampsia [J]. J Korean Med Sci, 2007,22(5):873- 877.
9Verlohren S, Herraiz I, Lapaire O, et al . New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia [J]. Hypertension, 2014,63 (2) : 346- 352.
10刘海意,刘玉凌,乔福元.正常妊娠与子痫前期胎盘VEGF及其受体mRNA差异表达的研究[J].中国妇幼保健,2008,23(12):1707-1709. 被引量：6